DECRYPTION – Several candidates, currently in development, could improve support.
Step by step, scientists are moving towards the development of blood tests to diagnose Alzheimer’s disease without having to resort to costly or painful examinations. The progress made over the past two years in this field now even gives hope for a real improvement in the management of this form of dementia which affects 1 million people in France.
On December 27, a new candidate with promising results was presented by an international team of scientists in the journal Brain . Their test searches blood plasma for a particular form of the Tau protein, the accumulation of which in the brain is a sign of Alzheimer’s. Experimentation on 600 volunteers recruited at different stages of the disease shows that this new biological marker is a good reflection of the results obtained thanks to the current examination – an analysis of cerebrospinal fluid taken by lumbar puncture. A few days earlier, Japan had authorized the…
This article is for subscribers only. You have 79% left to discover.
Pushing back the limits of science is also freedom.
Keep reading your article for €0.99 for the first month
Already subscribed? Login